# Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer

Source: https://onco.cc/trials/nct01057069/  
OnCo record `nct01057069` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2/3 trial of carboplatin, paclitaxel / nab-paclitaxel, doxorubicin, cyclophosphamide and other drugs in triple-negative breast cancer, run by The Netherlands Cancer Institute, active but no longer recruiting.

## Summary

Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer is a phase 2/3, randomised interventional study registered as NCT01057069 by The Netherlands Cancer Institute, with a registry enrolment figure of 310 participants, started 2010-01 and due to reach its primary completion in 2023-06. Interventions recorded: Carboplatin and Paclitaxel; Doxorubicin, cyclophosphamide; Doxorubicin, cyclophosphamide, carboplatin, thiotepa, cyclophosphamide. Conditions listed: Breast Cancer. Sites: Netherlands. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-24
- Also known as: neo-TN
- Tags: ctgov-ingest; tnbc-deep-dive
- Registry id: NCT01057069
- Phase: 2/3
- Setting: Randomized Phase II/III Study of Individualized Neoadjuvant Chemotherapy in ' Triple Negative' Breast Tumors
- Sponsor: The Netherlands Cancer Institute
- Enrolled: 310

## Sources

- ClinicalTrials.gov NCT01057069: https://clinicaltrials.gov/study/NCT01057069

## Connected records

- cancers: [Early triple-negative breast cancer](https://onco.cc/cancers/tnbc-early/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Platinum agents](https://onco.cc/technologies/platinum/)
- drugs: [Carboplatin](https://onco.cc/drugs/carboplatin/), [Cyclophosphamide](https://onco.cc/drugs/cyclophosphamide/), [Doxorubicin](https://onco.cc/drugs/doxorubicin/), [Paclitaxel / nab-paclitaxel](https://onco.cc/drugs/paclitaxel/), [Thiotepa](https://onco.cc/drugs/thiotepa/)
- terms: [Triple-negative breast cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/tnbc-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct01057069.json